AVP and myocardial infarction: Copeptin is significantly elevated in patients with stroke, acute myocardial infarction, heart failure, shock, and traumatic brain injury and has also been proposed to be a prognostic marker for poor clinical outcome and death in these patients5, 6, 7, 8, 9, 10.